Tranexamic acid (TXA), a synthetic lysine analogue, is an effective antifibrinolytic agent widely used for controlling excessive bleeding. Introduced in the 1960s, TXA competitively inhibits plasminogen activation, stabilizing fibrin clots. Large randomized trials, including CRA...
Tranexamic acid (TXA) is a synthetic antifibrinolytic agent that prevents fibrin clot degradation by inhibiting plasminogen activation. Widely used to reduce bleeding in trauma, surgery, and critical care, TXA has gained interest in cardiovascular patients receiving antithrombot...
If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of ceth.
Please Sign up.
To submit a manuscript, please visit the Clin Exp Thromb Hemost e-submission management system at http://submit.e-ceth.org, read the Instructions for Authors, and log into the Clin Exp Thromb Hemost e-submission system. For assistance with manuscript submission, please contact: ksth@thrombo.or.kr.
Free archive
Anyone may access any past or current articles without logging in.
Manuscript Submission